BioCorRx Inc. (14)

Browse by Contract Category

Contracts

Description of securities registered under Section 12 of the Exchange Act of 1934 (Filed With SEC on March 31, 2021)
Form of Subscription Agreement by and between BioCorRx Inc. and each of the Lucido and Galligan Trusts entered into on February 23, 2021 (Filed With SEC on February 26, 2021)
Second Amendment To Lease, dated July 11, 2019, by and between BioCorRx Inc. and Axis Campus Owner, LLC (Filed With SEC on November 14, 2019)
Master Services Agreement by and between BioCorRx Inc. and Charles River Laboratories Inc., dated May 24, 2019 (Filed With SEC on June 14, 2019)
Form of Galligan Director Agreement (Filed With SEC on February 22, 2021)
Conversion Agreement, dated September 30, 2019 by and between BioCorRx Inc., and BICX Holding Company LLC (Filed With SEC on October 4, 2019)
Lock-Up Agreement, dated September 30, 2019 by and between BioCorRx Inc., and BICX Holding Company LLC (Filed With SEC on October 4, 2019)
Statement of Work 1 by and between BioCorRx Inc. and Charles River Laboratories Inc., dated May 30, 2019 (Filed With SEC on June 14, 2019)
Statement of Work 2 by and between BioCorRx Inc. and Charles River Laboratories Inc., dated May 30, 2019 (Filed With SEC on June 14, 2019)
Subscription and Royalty Agreement by and between BioCorRx Inc. and Louis and Carolyn Lucido CRT LLC (Filed With SEC on April 3, 2019)
Subscription and Royalty Agreement by and between BioCorRx Inc. and J and R Galligan Revocable Trust (Filed With SEC on April 3, 2019)
Subscription Agreement dated February 22, 2019 (Filed With SEC on March 8, 2019)
Form of Director Agreement (Filed With SEC on March 7, 2019)
Form of Director Agreement (Filed With SEC on February 22, 2019)